BrightPath Biotherapeutics Co., Ltd. Share Price
Equities
4594
JP3274140007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59 JPY | +1.72% | 0.00% | -32.18% |
Sales 2017 | 529M 3.41M 284M | Sales 2018 | 354M 2.28M 190M | Capitalization | 33.68B 217M 18.05B |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.16M -597M | Net income 2018 | -1.58B -10.15M -845M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.86M 2.65B | Net cash position 2018 | 6.53B 42.02M 3.5B | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.53% |
1 day | +1.72% | ||
Current month | -1.67% | ||
1 month | -1.67% | ||
3 months | -11.94% | ||
6 months | -44.86% | ||
Current year | -32.18% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 01/09/01 |
Director/Board Member | 55 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 01/15/01 | |
Akira Yamada
BRD | Director/Board Member | 67 | 01/03/01 |
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 01/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 59 | +1.72% | 131 500 |
14/24/14 | 58 | +1.75% | 325,100 |
13/24/13 | 57 | 0.00% | 248,600 |
10/24/10 | 57 | -1.72% | 447,500 |
09/24/09 | 58 | -1.69% | 285,600 |
Delayed Quote Japan Exchange, May 15, 2024 at 11:30 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-32.18% | 26.23M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.67% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- 4594 Stock